A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 3 Trial of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Treatment-Naive Metastatic Pancreatic Ductal Adenocarcinoma
Patologie
Stato
Autorizzato - In attesa di apertura
Codice studio
PRISM-1
Codice EudraCT
2024-513317-12-00
Sponsor/Promotore
Arcus Biosciences, Inc.
Tipologia
Sperimentale
Fase
III
Unità Operativa
Oncologia 1
Principal Investigator